<--- Back to Details
First PageDocument Content
Medicine / Pharmacology / Endocrine disruptor / Dose-response relationship / No observable adverse effect level / Hormone / Endocrine system / Dose / Bisphenol A / Toxicology / Endocrinology / Biology
Date: 2013-04-03 09:55:54
Medicine
Pharmacology
Endocrine disruptor
Dose-response relationship
No observable adverse effect level
Hormone
Endocrine system
Dose
Bisphenol A
Toxicology
Endocrinology
Biology

Add to Reading List

Source URL: www.plasticseurope.org

Download Document from Source Website

File Size: 130,14 KB

Share Document on Facebook

Similar Documents

Draft IRIS Summary Do not cite or quoteThis document is in draft form. It has not been formally released by the U.S. Environmental Protection Agency and should not at this stage be construed to represent Agenc

Draft IRIS Summary Do not cite or quoteThis document is in draft form. It has not been formally released by the U.S. Environmental Protection Agency and should not at this stage be construed to represent Agenc

DocID: 19WId - View Document

READER FACT SHEETS UNDESIRABLE SUBSTANCES INDEX

READER FACT SHEETS UNDESIRABLE SUBSTANCES INDEX

DocID: 16WXz - View Document

Hazard assessment of nanomaterials in consumer products Environmental project No. 1637, 2015  Title:

Hazard assessment of nanomaterials in consumer products Environmental project No. 1637, 2015 Title:

DocID: 16Uhb - View Document

PM 8/12 Low-dose effects of Bisphenol A – identification of points of departure for the derivation of an alternative reference dose

PM 8/12 Low-dose effects of Bisphenol A – identification of points of departure for the derivation of an alternative reference dose

DocID: 16D4b - View Document

PDF Document

DocID: 16dNl - View Document